Partner Content Partner Content Join Pharmaceutical Social Media Experts in Just 1 Week! Only 1 Week Remains! #pharmasocialmedia
Events Partner Content The science of effective patient support Free workshop reframing what good patient comms are
Events Partner Content 10th Risk Evaluation & Mitigation Strategies Summit 10th Risk Evaluation & Mitigation Strategies Summit
Partner Content Partner Content Join Pharmaceutical Social Media Experts in Just 2 Weeks! On... Social Media in Pharma Conference
Partner Content Partner Content Potential Breakthrough Treatment for Erectile Dysfunction POTENTIAL BREAKTHROUGH TREATMENT FOR ED
Events Partner Content 3rd International Conference on Pancreatic Cancer and Liver ... Making Life Better: Fight Against Pancreatic Cancer
News Gilead strikes again, penning $5bn deal to buy Tubulis Gilead has signed its third acquisition deal since the start of the year, agreeing to buy ADC specialist Tubulis for $3.15bn upfront.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
